Dark

Check out our Dark Pool Levels

CCEL
Cryo-Cell International Inc.
stock NYSEAMERICAN

At Close

Jul 9, 2026 1:54:14 PM EDT

3.56USD+3.687%(+0.13)5,633

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-3.43)0

After-hours

Jul 9, 2026 4:10:30 PM EDT

3.54USD-0.590%(-0.02)1

OverviewHistoricalExchangesShortsNews

Oct 27, 2021

04:15PM EDT Cord Blood Banking Leader Cryo-Cell Announces Its Intent to GlobeNewswire Inc

Oct 15, 2021

04:37PM EDT Cryo-Cell Reports Q3 2021 Revs $7.5M Benzinga

04:36PM EDT Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2021. GlobeNewswire Inc

Sep 20, 2021

06:05PM EDT Cryo-Cell International Announces Changes To Its Board of Directors GlobeNewswire Inc

Sep 3, 2021

07:31AM EDT The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself Benzinga

Sep 2, 2021

08:20AM EDT The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab Benzinga

Aug 31, 2021

08:15AM EDT The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical Benzinga

Aug 30, 2021

09:00AM EDT Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Companys Common Stock Has Been Approved For Listing On The Nasdaq Capital Market (Nasdaq). GlobeNewswire Inc

Aug 20, 2021

09:05AM EDT Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area. GlobeNewswire Inc

Aug 11, 2021

09:00AM EDT Cryo-Cell International announces that Chairman of the Board and Co-CEO, David Portnoy, will be presenting at the Q3 Virtual Investor Summit on August 18th, 2021. GlobeNewswire Inc

Jul 15, 2021

07:28PM EDT Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2021. GlobeNewswire Inc

May 10, 2021

09:00AM EDT Cryo-Cell International Proudly AnnouncesTwo Ongoing GlobeNewswire Inc

Apr 14, 2021

06:14PM EDT Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2021. GlobeNewswire Inc

Feb 26, 2021

09:30AM EST Cryo-Cell International, Inc. (symbol: CCEL), the worlds first private cord blood bank to separate and store stem cells, has entered into a collaborative license agreement with Duke University. The agreement grants Cryo-Cell the rights to proprietary processes and regulatory data related to cord blood and cord tissue developed at Duke. GlobeNewswire Inc

Feb 24, 2021

04:30PM EST Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2020. GlobeNewswire Inc

Oct 15, 2020

04:39PM EDT Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2020. GlobeNewswire Inc

Jul 17, 2020

10:36AM EDT Insider Buys Cryo-Cell International Stock Benzinga

Share